Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IKZF2, also known as Helios, is a transcription factor belonging to the Ikaros family of zinc-finger proteins. It plays a critical role in hematopoietic development, particularly in lymphocyte differentiation and function, and regulates immune responses by controlling effector functions of regulatory T cells. While it functions as a tumor suppressor in some leukemias, it can contribute to leukemogenesis in specific genetic contexts like MLL-rearranged leukemia. Mutations or dysregulation can result in primary immunodeficiency diseases and aberrant antibody responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ikaros family zinc finger 2 (IKZF2).